Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.

F PoullenotA AmiotM NachuryS ViennotR AltweggY BouhnikV AbitbolS NanceyL VuittonL Peyrin-BirouletA BironM FumeryL PiconM VidonCatherine ReenaersM SerreroG SavoyeL BeaugeriePauline RiviereD Laharie

Published in: Journal of Crohn's & colitis (2022)

In this large multicentre cohort study, there was no difference of cancer incidence in those IBD patients with prior non-digestive malignancy, treated with vedolizumab or anti-TNF.

Keyphrases

patients with inflammatory bowel disease
papillary thyroid
squamous cell
clinical trial
study protocol
cardiovascular disease
rheumatoid arthritis
cross sectional
ulcerative colitis
lymph node metastasis
risk factors
squamous cell carcinoma
randomized controlled trial
type diabetes
double blind